Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Apellis Pharmaceuticals (APLS) Shares Issued (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Shares Issued readings, the most recent being $1.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 261.06% year-over-year to $1.2 million, compared with a TTM value of $3.4 million through Dec 2025, down 76.6%, and an annual FY2025 reading of $3.4 million, down 76.6% over the prior year.
  • Shares Issued hit $1.2 million in Q4 2025 for Apellis Pharmaceuticals, up from -$2.5 million in the prior quarter.
  • The five-year high for Shares Issued was $380.1 million in Q1 2022, with the low at -$377.6 million in Q3 2022.
  • Median Shares Issued over the past 5 years was $1.7 million (2022), compared with a mean of $22.6 million.
  • The largest YoY upside for Shares Issued was 14587.79% in 2022 against a maximum downside of 4648.35% in 2022.
  • Year by year, Shares Issued stood at $378.7 million in 2021, then plummeted by 99.55% to $1.7 million in 2022, then decreased by 4.86% to $1.6 million in 2023, then crashed by 80.23% to $321000.0 in 2024, then surged by 261.06% to $1.2 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $1.2 million, -$2.5 million, and $4.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.